.jpg "Kathy Neuzil, MD, MPH photo")
Director of the Center for Vaccine Development and Global Health
University of Maryland School of Medicine
Kathleen M. Neuzil, MD, MPH, FIDSA, FACP
The Myron M. Levine MD DTPH Professor in Vaccinology
Director, Center for Vaccine Development and Global Health
Chief, Division of Geographic Medicine, Department of Medicine
University of Maryland School of Medicine
Dr. Kathleen Neuzil is the Myron M. Levine MD DTPH Professor in Vaccinology, a Professor of Medicine and Pediatrics, and the Director of the Center for Vaccine Development and Global Health (CVD) at the University of Maryland School of Medicine. She is an internationally recognized research scientist, an advocate in the field of vaccinology, and a member of the prestigious National Academy of Medicine.
Throughout her career, Dr. Neuzil has conducted clinical and epidemiologic studies on vaccine-preventable diseases, yielding high profile publications that inform domestic and international policy decisions and public health actions. Dr. Neuzil’s work has spanned dozens of low resource countries with multiple vaccines, including influenza, rotavirus, HPV, Japanese encephalitis, and typhoid conjugate vaccines. Dr. Neuzil’s prolific research portfolio includes a 7-year NIH contract for a Collaborative Influenza Vaccine Innovation Center (CIVIC) Clinical Core to develop and test more broadly reactive and longer lasting influenza vaccines. Dr. Neuzil is the PI of a T32 Training Program in Vaccinology. She has more than 200 scientific publications on vaccines and infectious diseases.
Dr. Neuzil's research capabilities are complimented by 20 years of involvement in domestic and international policy, including past membership on the CDC’s Advisory Committee on Immunization Practices. She is currently the only U.S. member of the World Health Organization Strategic Advisory Group of Experts on Immunization (SAGE).
Dr. Neuzil is central to the domestic and global response to COVID. As a co-PI of the NIH-funded Leadership Group for the Vaccine and Treatment Evaluation Unit network, Dr. Neuzil is part of the strategic team evaluating COVID vaccines and therapeutics in the US, and was part of the study team who designed the first COVID-19 clinical vaccine trial in the US. The CVD is likewise participating in COVID treatment and post-exposure prophylaxis trials. As a member of SAGE, she will be advising the WHO on use of COVID-19 vaccines when they become available.
Dr. Neuzil graduated summa cum laude from the University of Maryland, and she received her medical degree from Johns Hopkins University School of Medicine where she was selected to AOA. She completed her Internal Medicine and Infectious Diseases training at Vanderbilt and receive her Masters of Public Health degree from Vanderbilt. She received the Vanderbilt Distinguished Alumna Award in 2016.
Disclosure: Nothing to Disclose
Thursday, October 22, 2020
12:30pm – 1:45pm EDT
Friday, October 23, 2020
11:30am – 12:45pm EDT
Friday, October 23, 2020
2:45pm – 4:00pm EDT
